The fluorescein conjugate, 
INTRODUCTION
Measurement of radioligand binding to receptors is routinely employed to study many aspects of receptor physiology and pharmacology [1, 2] . Recently, we reported that fluorescent ligands could be used to quanti- tate ligand-receptor interactions at central and peripheral benzodiazepine receptors in broken cell preparations [3] [4] [5] . Moreover, direct imaging of benzodiazepine [6] and dopamine [7] [8] [9] [10] [11] receptors using fluorescent ligands also has been described.
Adenosine functions as a central [12] and peripheral [13] neuromodulator through at least two G protein-coupled receptors. Al-adenosine receptors [14] inhibit adenylate cyclase and may be linked to other second-messenger systems, while A2-adenosine receptors stimulate cyclic AMP production [15] . A subclass of A2-adenosine receptors that occurs with a high density in the striatum and has a high affinity for agonist ligands has been termed the A2a-adenosine receptor [15] . Activation of vascular A2a-adenosine receptors in the central nervous system (CNS) yields behavioral depression [16] . Central A2~-adenosine receptors are associated with CNS control of respiration, by modulating sensory inputs originating in carotid body chemoreceptors and controlling cardiovascular functions through the nucleus tractus solitarius [12] . An association between A2~-adenosine receptors and the postsynaptic dopaminergic system also has been proposed [17, 18] . Moreover, A2~-adenosine receptor agonists have shown antipsychotic-like effects [17] .
In the present study, a fluorescent ligand having a high affinity for A2,-adeonsine receptors [12] [13] [14] [15] 19] [20] .
The fluorescent product, FITC-APEC, 2, retained a high affinity for A2a-adenosine receptors relative to the parent molecule. In the present report, we describe the first biochemical and pharmacological characterization of ligand binding to Aza-adenosine receptors in bovine striatal membranes by direct fluorescence measurement of FITC-APEC.
MATERIALS AND METHODS

Synthesis
Proton nuclear magnetic resonance spectra (300 MHz) were measured using a Varian XL-300 FT-NMR spectrometer. Californium plasma desorption mass spectra in the positive ion mode were performed by a method used previously for adenosine derivatives [20] ..Adenosine receptor ligands were obtained from Research Biochemicals Inc. (Natick, MA). APEC ( Fig. 1, 1 ) was prepared as described previously [20] . (Fig. 1, 2 ). APEC (6.5 mg, 11.1 txmol), 1, was dissolved in 0.5 ml of 1:1 acetonitrile:isopropanol and treated with 4.8 mg (12.3 ~mol) of fluoreseein isothiocyanate (Isomer I, Aldrich Chemical Co., Milwaukee, WI). After 24 h, the mixture was reduced in volume by evaporation under a stream of nitrogen. Acetonitrile and ether were added to precipitate the product. The product was recrystallized from DMF/acetonitrile/ether to yield 6.0 mg (58% yield). The 300-MHz 1H-NMR spectrum and Californium plasma desorption mass spectrum (peaks at mass 921.5, 898.9, 725.9) were consistent with the assigned structure.
2-[2-[4-
The product was also synthesized via carbodiimide coupling of CGS 21680 (2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine; Research Biochemicals Inc., Natick, MA) to 5-((2-aminoethyl)thioureidyl)fluorescein (Molecular Probes, Inc., Eugene, OR) in dimethylforrnamide.
The product was purified to > 99% purity by reverse-phase high-pressure liquid chromatography, using a 20-rain gradient of 0 to 80% acetonitrile in water (both containing 0.1% trifiuoroacetic acid), using a Vydac Protein C4 column (25 x 0.4 cm). One hundred microliters of a 1 mM solution in dimethyl sulfoxide was applied for each purification run. Larger quantities were readily purified on a semipreparative column. The retention time for the product was 14.1 rain. APEC (the starting material) was shown to be > 94% pure, with a retention time of 10.8 rain. The concentration of the probe in aqueous solution (pH 7.0) was calculated using an extinction coefficient of 67,200 at the Xm~ of 490.5 nm (quantum yield, 15.7%).
Tissue Preparation
Striatal tissues obtained from bovine brain (PeI-Freeze Biologicals, Rogers, AR) were placed in 10 vol of 0.32 M sucrose. Tissues were homogenized using a Teflon pestle and a glass tube (6-7 passes) and centrifuged at 600g for 10 rain (4~ The pellet was discarded and the supernatant recentrifuged at 37,000g for 1 h (4~ The resultant pellet was resuspended in ice-cold distilled water using a Brinkmann Polytron (setting 6-7, for 3 s) and centrifuged (4~ at 37,000g for 1 h. The pellet was resuspended again in buffer (50 mM Tris-HCl, pH 7.4 at 40C) and centrifuged. The pellet was resuspended in 2 vol (wt:vol, original wet weight) of buffer and stored at -800C for 1-3 days prior to binding assays. Adenosine deaminase (Boehringer Mannheim Biochemicals, Indianapolis, IN; 20 ~g/mg original tissue weight) from calf intestine (Fraction IV) was included in the incubation media to eliminate endogenous adenosine. Protein quantities were assessed using the Pierce BCA Protein Assay Reagent (Rockford, IL). 
FITC-APEC Binding
Fluorescence intensity (counts per second; cps) was measured using a SPEX Fluorolog Model 1680 0.22-m Double Spectrometer with DM3000 software (SPEX Industries, Edison, NJ). Excitation and emission spectra were measured by placing FITC-APEC (1 ~ in buffer (50 mM Tris-HC1 containing 10 mM MgC12, pH 7.4 or 8.1 at room temperature) or in a tissue suspension equivalent in concentration to that used for fluorescent ligand binding experiments. The excitation and emission maxima for FITC-APEC were 492 and 516 nm, respectively. Neither these values nor the fluorescence intensity of FITC-APEC was significantly altered by buffer composition, temperature, or drugs included in the assay.
The association rate of FITC-APEC was determined by incubating bovine striatal membranes in polypropylene microcentrifuge tubes (1.5 ml) containing buffer (50 mM Tris-HC1 plus 10 mM MgC12, pH 7.4 at room temperature) and FITC-APEC (50 nM) for 1-130 min. The 1-ml incubation mixture consisted of the following: 700 ~1 buffer, 100 ~xl bovine striatal tissue suspension (typically 300 ~xg protein per assay tube containing adenosine deaminase, 20 txg/mg original tissue weight from calf intestine, Fraction IV), 100 ~xl FITC-APEC (50 nM), and 100 ~1 2-chloroadenosine (2-CADO, 10 g.M to define nonspecific binding; Research Biochemicals Inc., Natick, MA), or buffer. Following each incubation interval, reactions were terminated by centrifugation for 20 rain at 20,000g (4~ The pellets were rinsed superficially with 2 x 1.0-ml aliquots of buffer and resuspended by sonication (3-s pulse, 50% setting) using an Ultrasonic Homogenizer (Cole-Parmer Instrument Co., Chicago, IL) in the original buffer volume. The buffer pH was adjusted to 8.1 prior to analysis of the samples.
Following the final centrifugation, the portion of each tube containing the tissue pellet was cut off and transferred to polystyrene cuvettes (Sarstedt, Newton, NC) containing 1 ml of buffer, and the fluorescence intensity measured. Dissociation studies were performed by incubating membranes with FITC-APEC (50 nM) for 90 rain prior to the addition of i ml of buffer (4~ plus 10 laM 2-CADO to initiate reversal of FITC-APEC binding. At the appropriate dissociation interval (1 s-25 min), the reactions were terminated by centrifugation (20,000g for 20 min at 4~ and the fluorescence intensity determined.
Saturation isotherms were constructed by incubating bovine striatal membranes at room temperature for 90 rain with 16-256 nM FITC-APEC. The assay parameters used were identical to those described for the association studies.
Quantitative analysis of FITC-APEC binding was performed by generating a standard line relating fluorescence intensity (cps) emitted by FITC-APEC (0.5-1024 nM) to known concentrations of fluorescent compound in buffer (free FITC-APEC) or tissue suspension (bound FITC-APEC) [3] [4] [5] . Bound and free ligand concentrations were subsequently estimated using linear regression analysis (GraphPAD, ISS Software, San Diego, CA). The selectivity of FITC-APEC (50 nM) binding to A2a-adenosine receptors in bovine striatal membranes was examined with the following substances using the indicated concentration ranges: 2-CADO (3-6600 nM), N 6-cyclohexyladenosine (CHA; 3-6600 riM), 2- 
Radioligand Binding
Radioligand binding assays using bovine striatal A2~-adenosine receptors were performed as described [21] . 
RESULTS
The binding of FITC-APEC (50 riM) (Fig. 1) , to bovine striatal A2a-adenosine receptors reached equilibrium within 60 rain and was stable for at least 130 min (Fig. 2) . A 90-min incubation period was used in subsequent experiments. FITC-APEC binding to A2a-adenosine receptors exhibited a kobs of 0.029 min -1 and a kl of 7.47 x 106 M -1 rain -I. The dissociation of FITC-APEC initiated by the addition of 10 g3,/2-CADO was rapid, with an estimated k.1 of 0.345 min -1 (Fig. 2) . The KD of FITC-APEC calculated by nonequilibrium parameters (KD = kJkl) was 46 nM. Saturation experiments were performed using 16-248 nM FITC-APEC (Fig. 3) . The KD and Bmax values determined for FITC-APEC were 57 _ 2 nM and 2. CADO, and CV 1808 (adenosine derivatives displaying a high affinity and/or moderate selectivity at A2a-adenosine receptors [19] ) are illustrated in Fig. 4 . Inhibition constants (Ki) generated for various known A2a-adenosine receptor ligands and several adenosine derivatives that do not recognize A2a-adenosine receptors with a high affinity are shown in Table I . The Ki v~lue for FITC-APEC to inhibit [3H]CGS 21680 (6.0 nM) binding to bovine striatal membranes was 11 _ 0.3 nM. The potencies of Az~-adenosine receptor ligands to inhibit FITC-APEC binding were highly correlated (r = 0.97, P = 0.0003) with their potencies to inhibit radioligand binding (Fig. 5 ).
DISCUSSION
The data reported here provide the first description of the biochemical and pharmacological characteristics of FITC-APEC binding to bovine striatal A2a-adenosine receptors determined by direct fluorescence measurement. The synthesis of a fluorescent ligand for A2a-adenosine receptors was accomplished by attaching APEC to fluorescein isothiocyanate (Fig. 1) . APEC is an amine functionalized congener that may be acylated to yield conjugates with a high affinity and selectivity at A2,-adenosine receptors [20] . For example, a biotin conjugate of APEC is > 500-fold selective for A2a-versus A1-adenosine receptors. APEC contains two modifications of adenosine that favor A2~-adenosine receptors: the 5'-CONH-CH2CH 3 group and an arylalkylamino group at the 2-position of the purine ring. APEC has a high potency as an A2a-adenosine receptor agonist both in vitro and in vivo [16] . While the synthesis of fluorescent adenosine receptor ligands was reported previously [22] , these derivatives are selective for Al-adenosine receptors and their usefulness for direct fluorescence measurement of receptors has not been described 9
Attachment of FITC to APEC at the terminal amino position resulted in a compound (FITC-APEC) with an affinity approximately one order of magnitude less than that of the parent compound (57 vs 6 nM assessed by radioligand binding) [20] . Based on the moderately reduced potencies of other fluorescent ligands, the affinity of FITC-APEC was sufficiently high to permit validation studies of its potential as a novel fluorescent ligand. Other studies have shown that attachment of fluorescent substituents to high-affinity central benzodiazepine [3, 4, 6, 24] , peripheral benzodiazepine [5] , and dopamine [7, 9] receptor ligands results in a similar or more dramatic reduction in affinity of the parent molecule. One possibility is that coupling a large fluorescent moiety to a high-affinity molecule (Fig. 1 ) may restrict access to the receptor, thus yielding a moderate decrease in affinity. Another possibility is the detrimental influence on affinity of a negative charge on a chain, which is noted as a general phenomenon for adenosine receptor ligands [22] .
FITC-APEC binding to bovine striatal membranes was saturable, with the estimated KD (57 --+ 2 riM) similar to the Ki value obtained in competition studies using [3H]CGS 21680 (11 + 0.3 nM). These values also correspond to the K D of FITC-APEC estimated by non- found by using A2a-adenosine receptor radioligands [17, 25, 26] for similarly prepared tissues of various animal species (i.e., bovine, guinea pig, man, mouse, rabbit, and rat). Despite the moderate differences in Bma x obtained using fluorescent ligand and radioligand binding techniques, FITC-APEC binding was inhibited by compounds that recognize A2a-adenosine receptors in a competitive manner, while agents that do not interact with A2a-adenosine receptors did not inhibit FITC-APEC binding (Fig. 4 , Table I ). The rank order of potency found for the inhibitors was that expected for A2a-adenosine receptors [19] . Moreover, an excellent correlation (r = 0.97, P = 0. Fig. 4 and Table I. [aH]NECA inhibition data were from the report by Bruns et al. [23] . The following compounds were used in the graph: NECA, DPMA, 2-CADO, CHA, R-PIA, CV 1808, and theophylline. The correlation coefficient for inhibition of FITC-APEC binding versus [3H]NECA binding was r = 0.97 (P = 0.0003).
inhibitors of FITC-APEC and [3H]NECA binding [23] ( Fig. 5) . These data strongly indicate that FITC-APEC labels an A2a-adenosine receptor. The most potent compounds in the fluorescence assay, NECA and DPMA, are among the most potent agonists known at A2a-adenosine receptors. 2-CADO, CHA, and R-PIA displayed an intermediate affinity, consistent with the A1 selectivity of these N6-substituted adenosine derivatives [19] . CV 1808, although slightly A2a-adenosine receptor selective [23] , was of a submicromolar affinity in the fluorescence assay and in agreement with the Ki value determined by radioligand binding. The fluorescence method was of a sufficient sensitivity to measure competition by a weak and nonselective adenosine antagonist, theophylline. ARA-A, a diastereomer of adenosine that does not bind to adenosine receptors, did not displace FITC-APEC from bovine striatal A2a-adenosine receptors. Likewise, guanosine derivatives are not adenosine receptor ligands, and 5'-GMP did not displace FITC-APEC binding.
FITC-APEC is a novel, high-affinity, and selective fluorescent ligand for Aza-adenosine receptors. This compound may be a useful tool both in pharmacological studies and to gain further insight into the physiological role of Ae,-adenosine receptors. FITC-APEC is of potential use in histochemical studies and cell sorting. The feasibility of using fluorescence techniques to measure quantitatively ligand-receptor interactions has now been evidenced using divergent types of receptors and ligands (Refs. 3-5 and this report). This technique provides a complementary method to existing techniques that employ radioactive materials and is economical and free of the potential health hazards and disposal problems associated with radioactive materials.
